Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer Medicine|November 10, 2023
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620LTakehiro Uemura, Hirotsugu Kenmotsu, Daisuke Hazama, et al.
Annals of the American Thoracic Society|March 2, 2017
Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with AsthmaTakamitsu Asano, Yoshihiro Kanemitsu, Masaya Takemura, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 3, 2021
Nasal polyp eosinophilia and FeNO may predict asthma symptoms development after endoscopic sinus surgery in CRS patients without asthmaRyota Kurokawa, Yoshihiro Kanemitsu, Kensuke Fukumitsu, et al.
JTO Clinical and Research Reports|February 11, 2022
A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLCDaichi Fujimoto, Satoru Miura, Kenichi Yoshimura, et al.
International Archives of Allergy and Immunology|January 16, 2022
Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naïve AsthmaKensuke Fukumitsu, Hirono Nishiyama, Yoshihiro Kanemitsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2025
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET)Hiroaki Akamatsu, Shinya Sakata, Koichi Azuma, et al.
Asia-Pacific Journal of Clinical Oncology|April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patientsYoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.
Cancer Medicine|November 21, 2023
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary studyYoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, et al.
Allergy, Asthma & Immunology Research|June 1, 2026
Risk Factors for COVID-19 mRNA Vaccine-Associated Exacerbations in Patients With Obstructive Airway Diseases: REsearch for Asthma and COPD ExacerbaTION Caused by COVID-19 mRNA Vaccination (REACTION Study)Tatsuro Suzuki, Yoshihiro Kanemitsu, Naoya Sugimoto, et al.
Pageof 11